Back to PRLD

D. E. Shaw & Co., Inc. → PRLD

D. E. Shaw & Co., Inc. PRLD Position History

Prelude Therapeutics Incorporated • Healthcare

Quarters held
7
Latest value
$95K
Q3 2026
Peak value
$605K
First seen
Q2 2022

Dollar value over time

Show data table
PeriodPosition value
Q2 2022$605K
Q3 2022$521K
Q4 2022$411K
Q1 2023$269K
Q2 2023$251K
Q3 2023$152K
Q3 2026$95K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$95K24.4K——
Q3 2023$152K49.2K——
Q2 2023$251K55.8K——
Q1 2023$269K47.2K——
Q4 2022$411K68.0K——
Q3 2022$521K78.9K——
Q2 2022$605K115.9K——

Other funds holding PRLD

Other D. E. Shaw & Co., Inc. positions

SPY

STATE STR SPDR S&P 500 ETF T

$7.6B
SPY

STATE STR SPDR S&P 500 ETF T

$6.8B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
SPY

SPDR S&P 500 ETF TR

$2B
NVDA

NVIDIA CORPORATION

$2B